中华放射肿瘤学杂志
Sunday, Apr. 6, 2025   Home | Journal | Editorial | Instruction | Subscription | Advertisement | Academic | Index-in | Contact Us | Chinese
Chinese Journal of Radiation Oncology  2013, Vol. 22 Issue (6): 465-468    DOI: 10.3760/cma.j.issn.1004-4221.2013.06.012
Head and Neck Tumors Current Issue| Next Issue| Archive| Adv Search [an error occurred while processing this directive] | [an error occurred while processing this directive]
Clinical analysis of risk factors for sensorineural hearing loss in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
MAO Yun-fei*, ZHANG Hong-yan, GAO-Jin, LIU Lei,YAN Bing, SHEN Fang.*
Department of Radiation Oncology, Anhui Provincial Hospital of Anhui Medical University, Hefei 230000, China
Download: PDF (0 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      Supporting Info
Abstract  Objective To investigate the risk factors for sensorineural hearing loss (SNHL) inpatients with nasopharyngeal carcinoma (NPC) after intensity-modulated radiotherapy (IMRT). MethodsFrom January 2012 to January 2013, 29 patients with histopathologically confirmed NPC who received radiotherapy alone or concurrent chemoradiotherapy were included in this study. All patients underwent hearing tests, including pure tone audiometry and acoustic immittance measurement, before and after the IMRT. The cochlear doses for each ear were also collected for analysis. A prospective analysis was performed to investigate the relationship between cochlear dose and SNHL in patients with NPC, and the effects of other factors, including time after radiotherapy, chemotherapy, T stage, and age, were also analyzed. Results Of the 58 ears studied, 6(10%) had low-frequency SNHL, and 17(29%) had high-frequency SNHL. There were significant differences in mean cochlear doses between the patients who developed SNHL after radiotherapy and those who did not (left ears:46.1 Gy vs. 35.5 Gy, P=0.006;right ears:45.0 Gy vs. 35.8 Gy, P=0.009). When the mean cochlear dose was less than 44 Gy, only 15%(6/38) of ears had high-frequency SNHL. The invasion of skull base bone was also a significant risk factor for SNHL(P=0.047), but age, chemotherapy, and time after IMRT were not significant risk factors. Conclusions The mean cochlear dose and invasion of skull base bone are significant risk factors for SNHL in patients with NPC after radiotherapy. It is recommended that the mean cochlear dose should be limited to 44 Gy to minimize the incidence of SNHL after IMRT.
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
MAO Yun-fei
ZHANG Hong-yan
GAO-Jin
LIU Lei
YAN Bing
SHEN Fang.
Key wordsNasopharyngeal neoplasms/ intensity-modulated radiotherapy      Sensori-neural hearing loss      Pure tone audiometry      Acoustic immittance     
    
Corresponding Authors: ZHANG Hong-yan,Email:zhanghongyan3334@qq.com   
Cite this article:   
MAO Yun-fei,ZHANG Hong-yan,GAO-Jin et al. Clinical analysis of risk factors for sensorineural hearing loss in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy[J]. Chinese Journal of Radiation Oncology, 2013, 22(6): 465-468.
MAO Yun-fei,ZHANG Hong-yan,GAO-Jin et al. Clinical analysis of risk factors for sensorineural hearing loss in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy[J]. Chinese Journal of Radiation Oncology, 2013, 22(6): 465-468.
URL:  
http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.issn.1004-4221.2013.06.012     OR     http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2013/V22/I6/465
  Copyright © 2010 Editorial By Chinese Journal of Radiation Oncology
Support by Beijing Magtech Co.ltd  support@magtech.com.cn